EurekaMag.com logo
+ Site Statistics
References:
52,654,530
Abstracts:
29,560,856
PMIDs:
28,072,755
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on LinkedInFollow on LinkedIn

+ Translate

The effect of the calcium antagonist flunarizine on sudden death protection from ventricular fibrillation



The effect of the calcium antagonist flunarizine on sudden death protection from ventricular fibrillation



FASEB Journal 5(4): A873




(PDF emailed within 1 workday: $29.90)

Accession: 033785409

Download citation: RISBibTeXText



Related references

Effect of potassium channel antagonist glibenclamide on sudden death protection from ventricular fibrillation. Journal of the American College of Cardiology 17(2 SUPPL A): 165A, 1991

Effect of calcium antagonists on sudden cardiac death protection from ventricular fibrillation. FASEB Journal 2(4): ABSTRACT 2908, 1988

Effect of calcium antagonists on cocaine induced sudden death protection from ventricular fibrillation. FASEB Journal 6(5): A1868, 1992

Effect of calcium channel antagonists on susceptibility to sudden cardiac death: protection from ventricular fibrillation. Journal of Pharmacology and Experimental Therapeutics 248(3): 1334-1342, 1989

The calcium channel antagonist, flunarizine, protects against ventricular fibrillation. European Journal of Pharmacology 212(2-3): 231-235, 1992

Effect of the cholinergic agonist carbachol and cyclic gmp on sudden cardiac death protection from ventricular fibrillation. Journal of the American College of Cardiology 13(2 SUPPL A): 91A, 1989

Effect of Omega-3 fatty acids on susceptibility to sudden death Protection from ventricular fibrillation during myocardial ischemia. Circulation 90(4 PART 2): I466, 1994

The KATP channel antagonist 5-hydroxydecanoate fails to protect against ventricular fibrillation in a conscious canine model of sudden cardiac death. FASEB Journal 9(3): A605, 1995

Induction of ventricular fibrillation during antiarrhythmic drug treatment predicts sudden death in patients with sustained monomorphic ventricular tachycardia or ventricular fibrillation after myocardial infarction. Circulation 90(4 PART 2): I455, 1994

Implantable cardioverter defibrillator for prevention of sudden cardiac death in patients with ventricular tachycardia and ventricular fibrillation: ICD therapy in sudden cardiac death. Pacing and Clinical Electrophysiology 16(3 Pt 2): 511-518, 1993

Cocaine-induced ventricular fibrillation: protection afforded by the calcium antagonist verapamil. Faseb Journal 2(14): 2990-2995, 1988

Effect of flecainide acetate on ventricular tachycardia induction and ventricular fibrillation prevention in a conscious canine model of sudden death. Journal of the American College of Cardiology 7(2 SUPPL A): 84A, 1986

Protection from ventricular fibrillation by um 272 2 hydroxy n n dimethyl n 1 methylethyl 3 1 naphthalenyloxy 1 propanaminium iodide in a conscious canine model of sudden coronary death. Federation Proceedings 41(5): ABSTRACT 8433, 1982

Risk factors for early death in ventricular tachy cardia and sudden death ventricular fibrillation patients despite intensive medical therapy. Clinical Research 29(2): 248A, 1981

Endurance exercise training normalizes repolarization and calcium-handling abnormalities, preventing ventricular fibrillation in a model of sudden cardiac death. Journal of Applied Physiology 113(11): 1772-1783, 2013